Dr. Reddy's Eyes 2012 Launch Of Generic Clarinex

Law360, New York (December 29, 2008, 12:00 AM EST) -- Schering Corp., Sepracor Inc. and Dr. Reddy's Laboratories Ltd. have struck settlement deals that should resolve litigation and allow the India-based generics maker to enter the $362 million annual U.S. market for the allergy drug Clarinex in 2012, Dr. Reddy's said.

Dr. Reddy's said the deals resolve all pending suits brought against Dr. Reddy's by Schering and Sepracor over Clarinex in the U.S. District Court for the District of New Jersey, adding that total U.S. sales for all formulations of Clarinex in 2007 were $362 million....
To view the full article, register now.